Pierre Kyme - 14 Mar 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Issuer symbol
ARMP
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 19:48:27 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kyme Pierre Chief Business Officer 5005 MCCONNELL AVENUE, LOS ANGELES /s/ Pierre Kyme 17 Mar 2026 0002028892

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Tax liability -1,030 -9.8% $10.54* 9,461 14 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.